alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid has been researched along with ym 872 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kawasaki-Yatsugi, S; Monette, R; Morley, P; Murray, CL; Small, DL | 1 |
| Hagimura, N; Ishiuchi, S; Kurihara, H; Miwa, A; Nakazato, Y; Okado, H; Ozawa, S; Sasaki, T; Tamura, M; Tsuzuki, K; Yamada, N; Yoshida, Y | 1 |
2 other study(ies) available for alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid and ym 872
| Article | Year |
|---|---|
Neuroprotective effects of a novel AMPA receptor antagonist, YM872.
Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Cell Survival; Cells, Cultured; Cerebral Cortex; Excitatory Postsynaptic Potentials; Fetus; Glucose; Hippocampus; Imidazoles; In Vitro Techniques; Microscopy, Confocal; Neurons; Neuroprotective Agents; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, AMPA | 1998 |
Blockage of Ca(2+)-permeable AMPA receptors suppresses migration and induces apoptosis in human glioblastoma cells.
Topics: Adenoviridae; alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Apoptosis; Brain Neoplasms; Calcium; Cell Movement; Genetic Vectors; Glioblastoma; Humans; Imidazoles; Mice; Mice, Nude; Permeability; Quinoxalines; Receptors, AMPA; Tumor Cells, Cultured | 2002 |